Dose Finding Study In Subjects With Crow's Feet
NCT01951742 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 145
Last updated 2014-05-29
Summary
The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.
Conditions
- Lateral Canthal Lines
- Crow's Feet
Interventions
- BIOLOGICAL
-
ANT-1401
Active
- BIOLOGICAL
-
Vehicle
Vehicle
Sponsors & Collaborators
-
Anterios Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2013-12-31
- Completion
- 2014-01-31
Countries
- United States
Study Locations
More Related Trials
-
BOTOX® in the Treatment of Upper Facial Lines in Japan
NCT01797094 ·Status: COMPLETED ·Phase: PHASE3
-
Infiltrations of OnaBotulinum Toxin A in Resistant Depression: Comparison of Two Facial Injection Sites.
NCT03484754 ·Status: UNKNOWN ·Phase: NA
-
ET-01 in Subjects With Lateral Canthal Lines, LCL-210
NCT04985916 ·Status: COMPLETED ·Phase: PHASE2
-
ET-01 in Subjects With Lateral Canthal Lines
NCT03326856 ·Status: COMPLETED ·Phase: PHASE2
-
MEDITOXIN® in Treatment of Crow's Feet Line
NCT03317574 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)
NCT00247559 ·Status: COMPLETED ·Phase: PHASE2
-
ET-01 in Subjects With Lateral Canthal Lines, LCL-208
NCT03839693 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection
NCT01688076 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
NCT02677805 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles
NCT02019004 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines
NCT03806933 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides
NCT01777620 ·Status: COMPLETED ·Phase: PHASE4
-
NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
NCT00777803 ·Status: COMPLETED ·Phase: PHASE3
-
Using Botox to Treat Patients With Idiopathic Clubfoot
NCT00474032 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows
NCT00752050 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01485601 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002 ·Status: COMPLETED ·Phase: PHASE2
-
Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines
NCT00430586 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
NCT06583486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001
NCT02334423 ·Status: COMPLETED ·Phase: PHASE3
-
Botox Cosmetic and the Young Patient With Glabellar Furrows
NCT00856999 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
NCT05218785 ·Status: RECRUITING
-
Study to Determine If the Volume Used to Dilute BOTOX Cosmetic™ for Injection Affects Its Overall Effect and Duration.
NCT00250952 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin Injections by Ultrasounds Guidance and Stretching Exercise in Spastic Toe Clawing
NCT02586142 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT00694148 ·Status: COMPLETED ·Phase: PHASE3